Haynes and Boone, LLP

Haynes and Boone, LLP is one of the largest and fastest-growing law firms in the U.S. Our firm believes that the world of business belongs to companies keen to compete, quick to adapt, eager to listen and learn and resolved to continually challenge themselves. We measure ourselves by the same standards. Our teamwork culture, our willingness to change quickly to meet the demands of the marketplace and our drive to be the best have been the key factors behind our success. We have grown from a handful of lawyers in 1970 to more than 525 attorneys and 30 major legal practice areas, have expanded to twelve offices worldwide and have become a national leader in the use of technology to deliver legal services. Our reputation in the business world has likewise grown.

We serve a diverse group of clients in a wide array of domestic and global business transactions and litigation matters. Our client base reflects virtually every business industry and includes more than 20 percent of the Fortune 500 companies, many major foreign companies and large financial institutions.

We have long served our clients' global business activities by building cross-border practice capabilities, strategically adding international legal expertise and establishing working relationships with leading law firms throughout the world. Haynes and Boone lawyers are proficient in 22 foreign languages. Our Mexico City office, opened in 1994, has grown to be one of the largest in Mexico among U.S. law firms, and our Moscow office was opened in 2005. Our global reach has included more than 100 foreign countries where we assisted clients in cross-border matters ranging from acquisitions and financings to dispute resolution.

Biosimilars: Draft Guidance Documents Issued by FDA
Kimberly Weinreich,Jeffrey A. Wolfson, February 14, 2012
The new abbreviated regulatory approval pathway for “biosimilar” and “interchangeable” types of biologic drug products was implemented in the Biologics Price Competition and Innovation Act of 2009 (BPCI Act) as part of the Patient Protection and Affordable Care Act of 2010....

Fifth Circuit Affirms Courts’ Discretion on Fee Methods in Common Fund Class Settlements
Nicholas Even,Sarah Mallett, February 14, 2012
The United States Court of Appeals for the Fifth Circuit has confirmed that lower courts may use their discretion in choosing either of two methods - the "percentage method" or "lodestar method" - to calculate attorneys' fees in class action suits. The decision, in Union Asset...

HIPAA Privacy and Security Audits Begin: Enforcement Measures May Follow
Michael L. Silhol, February 14, 2012
The Office for Civil Rights (OCR) of the U.S. Department of Health and Human Services has begun the pilot phase of HIPAA privacy and security audits of health care providers, health insurers and health care clearinghouses (“covered entities”) to assess HIPAA compliance efforts. Up to...